Post by WHU โ€“ Otto Beisheim School of Management

50,663 followers

๐—›๐—ผ๐˜„ ๐—ฎ ๐—ช๐—›๐—จ ๐—”๐—น๐˜‚๐—บ๐—ป๐˜‚๐˜€ ๐—œ๐˜€ ๐— ๐—ฎ๐—ธ๐—ถ๐—ป๐—ด ๐—Ÿ๐—ถ๐—ณ๐—ฒ-๐—–๐—ต๐—ฎ๐—ป๐—ด๐—ถ๐—ป๐—ด ๐—ง๐—ฟ๐—ฒ๐—ฎ๐˜๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐— ๐—ผ๐—ฟ๐—ฒ ๐—”๐—ฐ๐—ฐ๐—ฒ๐˜€๐˜€๐—ถ๐—ฏ๐—น๐—ฒ Millions of people live with diseases like type 1 diabetes or Parkinsonโ€™s. Not because science has no answers, but because treatments are often too expensive. WHU alumnus Konstantin Kurz co-founded BioThrust with a clear sense of responsibility: to rethink how cell therapies are produced. With a world-first, bubble-free bioreactor technology, the start-up aims to make the production of sensitive stem and immune cells more efficient and life-changing therapies more accessible. From WHU to biotech deep tech, this interview shows how responsible leadership and entrepreneurship can go hand in hand. Read the full interview via the link: https://lnkd.in/dJDva9hr #mywhu Maximilian Eckel

Post contentPost content